bp1.3656
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jan 9, 2018 (NCT03424824)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Histamine H3 receptorANTAGONIST
HRH3 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05240560 | Phase 2 | Sep 30, 2022 | Bioprojet, University of Bern |
| NCT04727086 | Phase 2 | Feb 1, 2021 | University of Toronto |
| NCT03424824 | Phase 2 | Jan 9, 2018 | Bioprojet |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bioprojet | For profit | 2 | 2 | 1 | 2018 |
| University of Bern | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Toronto | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1